Brigitte I. Frohnert, MD, PhD, delivered the presentation “Glucose Monitoring in Stage 2 Type 1 Diabetes” during the Expanding the Use of Continuous Glucose Monitoring in Pediatric Settings session on Friday, June 12. She said ongoing education and monitoring are key in preventing diabetic ketoacidosis at transition from stage 2 to stage 3 type 1 diabetes.
Brigitte I. Frohnert, MD, PhD, addresses glucose monitoring in stage 2 type 1 diabetes
